Renal Cancer
Multidrug resistance transporter profile reveals MDR3 as a marker for stratification of blastemal Wilms tumour patients
January 12, 2017
Immunotherapy: incorporation in the evolving paradigm of renal cancer management and future prospects
January 12, 2017
The association between age-related macular degeneration and renal cell carcinoma: a nested case-control study
January 12, 2017
Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma
January 11, 2017
Biological Features of a Renal Cell Carcinoma Cell Line Derived from Spinal Metastasis
January 11, 2017
SU-F-R-39: Effects of Radiation Dose Reduction On Renal Cell Carcinoma Discrimination Using Multi-Phasic CT Imaging
January 11, 2017
3D printed renal cancer models derived from MRI data: application in pre-surgical planning
January 9, 2017
Mixed Results for Sunitinib in Renal Cancer
January 9, 2017
Biological toxicities as surrogate markers of efficacy in patients treated with mTOR inhibitors for metastatic renal cell carcinoma
January 9, 2017
Oncology Gold Standardâ„¢ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma.
January 9, 2017
How clinical practice is changing the rules: the sunitinib 2/1 schedule in metastatic renal cell carcinoma
January 9, 2017
Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma
January 9, 2017
Prognostic Value of Plasma and Urine Glycosaminoglycan Scores in Clear Cell Renal Cell Carcinoma
December 29, 2016
Targeting HIF2 in Clear Cell Renal Cell Carcinoma
December 29, 2016
Laparoscopic Nephrectomy: Initial Case Report
December 29, 2016